Newsroom
Company News
₹110 Crore strategic investment from Piramal Alternatives
A landmark institutional investment to scale injectable capacity, strengthen our nasal spray leadership and expand export infrastructure.
Media & press
Working on a story?
For press enquiries, interviews, company facts or media assets, reach our communications team — we typically respond within 48 business hours.